Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence

Michael G. Aman, Goedele De Smedt, Albert Derivan, Ben Lyons, Robert L. Findling, Randi Hagerman, Benjamin Handen, Jessica Hellings, Michael Lesem, Jörg Pahl, Deborah A. Pearson, Michael Rieser, Nirbhay N. Singh, James Swanson

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence'. Together they form a unique fingerprint.

Medicine & Life Sciences